Predictive factors of vascular intima media thickness in HIV-positive subjects

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 195-199

  Bongiovanni, Marco ^a   Casana, M ^a   Cicconi, P ^a   Pisacreta, M ^b   Codemo, R ^b   Pelucchi, M ^b   d'Arminio Monforte, A ^a   Bini, T ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardiovascular risk; Doppler; HAART

Indexed keywords

GLUCOSE; HOMOCYSTEINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; FEMALE; FEMORAL ARTERY; HIV INFECTIONS; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; TUNICA INTIMA; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 37549054644     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm414     Document Type: Article

References (22)

1. Tabib A, Greenland T, Mercier I et al. Coronary lesions in young HIV-positive subjects at necropsy. Lancet 1992; 340: 730.
2. Lewis W, Lipsick J, Cammarosano C. Cryptococcal myocarditis in acquired immune deficiency syndrome. Am J Cardiol 1985; 55: 1240.
3. Grunfeld C, Pang M, Doerrler W et al. Lipids, lipoproteins, triglyceride, clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74: 1045-52.
4. Shor-Posner G, Basit A, Lu Y et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 1993; 94: 515-9.
5. Carr A, Samaras K, Burton S et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-8.
6. Friis-Moller N, Weber R, Reiss P et al. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-93.
7. Lipshultz SE, Fisher SD, Lai WW et al. Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS 2003; 17 Suppl 1: S96-122.
8. Currier J, Kendall MA, Zackin R et al. Carotid artery intima-media thickness and HIV infection: Traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 2005; 19: 927-33.
9. Maggi P, Lillo A, Perilli F et al. Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: A comparative study. AIDS 2004; 18: 1023-8.
10. Wood D, de Backer G, Faergeman O et al. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary prevention. Atherosclerosis 1998; 140: 199-270.
11. Martinez E, Mocroft A, Garcia-Viejo MA et al. Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: A prospective cohort study. Lancet 2001; 357: 592-8.
12. Vittecoq D, Escaut L, Chironi G et al. Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era. AIDS 2003; 17: S70-6.
13. Henry K, Melroe H, Huebsch J et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998; 351: 1328.
14. Friis-Moller N, Sabin CA, Weber R et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
15. Depairon M, Chessex S, Sudre P et al. Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy. AIDS 2001; 15: 329-34.
16. Chironi G, Escault L, Gariepy J et al. Carotid intima-media thickness in heavily pretreated HIV-infected patients. J Acquir Immune Defic Syndr 2003; 32: 490-3.
17. Hsue PY, Lo JC, Franklin A et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV-infection. Circulation 2004; 109: 1603-8.
18. Johnsen S, Dolan SE, Fitch KV et al. Carotid intima medial thickness in human immunodeficiency virus-infected women: Effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 4916-24.
19. Merciè P, Thiebaut R, Aurillac-Lavignolle V et al. Carotid intima-media thickness is slightly increased over time in HIV-1 infected patients. HIV Med 2005; 6: 380-7.
20. Bongiovanni M, Pisacreta M, Ortu M et al. Pseudoaneurysm of the femoral artery in a HIV-infected man. Eur J Vasc Endovasc Surg 2004; 28: 451-3.
21. Bernasconi E, Uhr M, Magenta L et al. Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy. AIDS 2001; 15: 1081-2.
22. Bongiovanni M, Casana M, Pisacreta M et al. Predictive factors of hyperhomocysteinaemia in HIV-positive patients. J Acquir Immune Defic Syndr 2007; 44: 117-9.